RU2010128019A - Пероральная диспергируемая таблетка - Google Patents

Пероральная диспергируемая таблетка Download PDF

Info

Publication number
RU2010128019A
RU2010128019A RU2010128019/15A RU2010128019A RU2010128019A RU 2010128019 A RU2010128019 A RU 2010128019A RU 2010128019/15 A RU2010128019/15 A RU 2010128019/15A RU 2010128019 A RU2010128019 A RU 2010128019A RU 2010128019 A RU2010128019 A RU 2010128019A
Authority
RU
Russia
Prior art keywords
tablet
tablet according
drugs
group
specified
Prior art date
Application number
RU2010128019/15A
Other languages
English (en)
Russian (ru)
Inventor
Тобиас ЛАИХ (DE)
Тобиас ЛАИХ
Томас ШТЕЕНПАСС (DE)
Томас ШТЕЕНПАСС
Original Assignee
Байер Шеринг Фарма Акциенгезельшафт (DE)
Байер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезельшафт (DE), Байер Шеринг Фарма Акциенгезельшафт filed Critical Байер Шеринг Фарма Акциенгезельшафт (DE)
Publication of RU2010128019A publication Critical patent/RU2010128019A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2010128019/15A 2007-12-08 2008-11-25 Пероральная диспергируемая таблетка RU2010128019A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023802 2007-12-08
EP07023802.7 2007-12-08

Publications (1)

Publication Number Publication Date
RU2010128019A true RU2010128019A (ru) 2012-01-20

Family

ID=40631079

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010128019/15A RU2010128019A (ru) 2007-12-08 2008-11-25 Пероральная диспергируемая таблетка

Country Status (9)

Country Link
EP (1) EP2231126A2 (zh)
JP (2) JP2011506279A (zh)
KR (1) KR20100096140A (zh)
CN (1) CN101888834A (zh)
BR (1) BRPI0820861A2 (zh)
MX (1) MX2010005175A (zh)
RU (1) RU2010128019A (zh)
TW (1) TW200938233A (zh)
WO (1) WO2009071219A2 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696050B2 (ja) * 2009-09-08 2015-04-08 協和化学工業株式会社 制酸・緩下用錠剤
CN101797236B (zh) * 2010-03-23 2012-05-23 西南大学 重酒石酸卡巴拉汀口腔崩解片及其制备方法
BR112012027303A2 (pt) * 2010-04-27 2017-10-24 Bayer Ip Gmbh comprimido de desintegração oral contendo acarbose
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
KR101237646B1 (ko) * 2010-12-09 2013-03-04 주식회사 드림파마 생체이용률이 개선된 셀레콕시브 함유 고체 분산체, 이를 포함하는 약학 조성물 및 이의 제조방법
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
TR201100150A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Suda çözünür dozaj formları
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
CN102600149B (zh) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 一种治疗糖尿病的药物组合物
EP3023109A4 (en) 2013-07-19 2017-01-04 Sanwa Kagaku Kenkyusho Co., Ltd Orally disintegrating tablet
WO2015007676A1 (en) * 2013-07-19 2015-01-22 Bayer Pharma Aktiengesellschaft Super quick disintegrating tablet formula for api miglitol
CN103877041B (zh) * 2014-03-14 2016-07-06 崔书豪 一种吡罗昔康分散片及其制备方法
WO2017130709A1 (ja) * 2016-01-29 2017-08-03 小林　光 固形製剤、固形製剤の製造方法及び水素発生方法
CN105640954B (zh) * 2016-02-04 2019-03-05 青岛市海慈医疗集团 一种治疗消化不良的西沙必利片剂
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11786471B2 (en) * 2016-07-11 2023-10-17 Wuhan Ll Science And Technology Development Co. Ltd. Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system
WO2018037819A1 (ja) 2016-08-23 2018-03-01 小林　光 配合物及びその製造方法、並びに水素供給方法
US11583483B2 (en) 2016-08-23 2023-02-21 Bosquet Silicon Corp. Hydrogen supply material and production therefor, and hydrogen supply method
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法
AU2018341729A1 (en) * 2017-09-28 2020-02-06 Hanmi Pharm. Co., Ltd. Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
CN109864971B (zh) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 一种拉莫三嗪固体分散体的颗粒剂及其制备方法
CN114224855B (zh) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 一种甲磺酸多沙唑嗪口含片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
EP1469829B1 (en) * 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CA2524806C (en) * 2003-05-07 2011-07-12 Akina, Inc. Highly plastic granules for making fast melting tablets
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
TW200938233A (en) 2009-09-16
BRPI0820861A2 (pt) 2015-06-16
JP2011506279A (ja) 2011-03-03
WO2009071219A3 (en) 2009-09-11
CN101888834A (zh) 2010-11-17
EP2231126A2 (en) 2010-09-29
WO2009071219A2 (en) 2009-06-11
JP2015038123A (ja) 2015-02-26
MX2010005175A (es) 2010-08-02
KR20100096140A (ko) 2010-09-01

Similar Documents

Publication Publication Date Title
RU2010128019A (ru) Пероральная диспергируемая таблетка
RU2011117177A (ru) ДОЗИРОВАННЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ 3-(6-(1-(2,2-ДИФТОРБЕНЗО[d][1,3]ДИОКСОЛ-5-ИЛ)ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
RU2017133990A (ru) Фармацевтические лекарственные формы ингибитора тирозинкиназы брутона
NZ600720A (en) A Seamless Capsule For A Liquid Pharmaceutical Composition
UY32599A (es) Formulación oral sólida de abt-263
UY27995A1 (es) Nuevas formulaciones farmacéuricas solidas que comprenden telmartisano y su preparación
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
HK1111609A1 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
AR052153A1 (es) Composiciones y metodos para la estabilizacion de ingredientes farmaceuticos activos
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
DK1820506T3 (da) Dipyridamol-formuleringer med forlænget frigivelse og fremgangsmåde til fremstilling heraf
RU2008135718A (ru) Композиции клопидогреля бисульфата
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
NO20024237L (no) Farmasöytiske formuleringer
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
DE602005008128D1 (de) Cytisinehaltiges Arzneimittel
ATE441410T1 (de) Fenofibrattabletten
ATE457721T1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
ATE401060T1 (de) Schnell zerfallende tablette
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
PE20040091A1 (es) Formulaciones farmaceuticas de liberacion controlada
WO2002067894A3 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20131209